MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20

The present invention relates to the field of bioengineering, and proposes a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA that codes for said antibody, the corresponding expression vectors and methods of production, as well as to treatment methods using said...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	USTIUGOV, IAKOV IUREVICH, KOSKOVA, SVETLANA VLADIMIROVNA, DIDUK, SERGEI VASILYEVICH, SOLOVYEV, VALERY VLADIMIROVICH, EROSHOVA, ANNA VLADIMIROVNA, IAKOVLEV, PAVEL ANDREEVICH, TRUDOVISHNIKOVA, ANNA ALEXANDROVNA, SMIRNOVA, IANA ANDREEVNA, SHELEVA, MARIIA ALEKSANDROVNA, USATOVA, VERONIKA SERGEEVNA, MOROZOV, DMITRY VALENTINOVICH, ANIKINA, ARINA VITALEVNA, KHARATIAN, NINA GRACHYAEVNA, ALEKSANDROV, ALEKSEI ALEKSANDROVICH, IVANOV, ROMAN ALEKSEEVICH, KRENDELEVA, ELENA ANDREEVNA, PESTOVA, NATALIA EUGENIEVNA, MISORIN, ALEXEY KONSTANTINOVICH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the field of bioengineering, and proposes a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA that codes for said antibody, the corresponding expression vectors and methods of production, as well as to treatment methods using said antibody. La présente invention concerne le domaine de la biotechnologie et porte sur un anticorps monoclonal qui se lie spécifiquement à CD20. L'invention concerne des ADN qui codent pour ledit anticorps, qui correspondent aux vecteurs d'expression, et des procédés de production ainsi que des méthodes de traitement utilisant ces anticorps.